Vontobel Holding Ltd. Silverback Therapeutics, Inc. Transaction History

Vontobel Holding Ltd.

  • $29.2 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jun 03, 2024
SELL
N/A
-83,345 Reduced 24.23%
260,684 $0
Q3 2023

Oct 10, 2023
SELL
N/A
-83,345 Reduced 24.23%
260,684 $0
Q2 2023

Jun 03, 2024
BUY
N/A
174,297 Added 102.69%
344,029 $0
Q2 2023

Jul 24, 2023
BUY
N/A
174,297 Added 102.69%
344,029 $0
Q1 2023

Jun 03, 2024
BUY
N/A
169,732 New
169,732 $0
Q1 2023

Apr 12, 2023
BUY
N/A
23,881 Added 16.37%
169,732 $0
Q4 2022

Feb 14, 2023
BUY
$0.0 - $6.07 $0 - $885,315
145,851 New
145,851 $0

Others Institutions Holding SBTX

# of Institutions
163
Shares Held
62.7M
Call Options Held
872K
Put Options Held
589K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email